logo

Kintara Therapeutics, Inc (KTRA)



Trade KTRA now with
  Date
  Headline
2/17/2021 8:24:55 AM Kintara Therapeutics Enrolls Final Patient In Phase 2 Clinical Trial Of VAL-083 For Recurrent GBM
1/13/2021 8:14:51 AM Kintara Initiates Patient Recruitment For VAL-083's Study Arm In GBM AGILE Trial
11/13/2020 8:06:50 AM Kintara Therapeutics Q1 Net Loss $19.5 Mln Or $1.33/shr Vs. Net Loss Of $1.6 Mln Or $0.21/shr Prior Year
10/21/2020 8:22:07 AM Kintara,e Global Coalition For Adaptive Research Execute Agreement For VAL-083's Participation In GBM AGILE Study